We are live on ! Find out more
CIP

Convergence Investment Partners Portfolio holdings

AUM $1.06B
1-Year Est. Return 87.75%
This Fund
S&P 500
This Quarter Est. Return
-4.2%
1 Year Est. Return
+87.75%
3 Year Est. Return
+284.26%
5 Year Est. Return
+379.02%
10 Year Est. Return
+1,390.46%
AUM
$153M
AUM Growth
-$12.1M
Cap. Flow
-$1.82M
Cap. Flow %
-1.19%
Top 10 Hldgs %
21.35%
Holding
258
New
56
Increased
66
Reduced
77
Closed
59

Top Buys

Rank Stock Value
1
LAZ icon
Lazard
LAZ
+$1.25M
2
GILD icon
Gilead Sciences
GILD
+$1.17M
3
EIX icon
Edison International
EIX
+$1.14M
4
AMGN icon
Amgen
AMGN
+$1.12M
5
CSCO icon
Cisco
CSCO
+$963K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$2.41M
2
HPQ icon
HP
HPQ
+$1.91M
3
MPC icon
Marathon Petroleum
MPC
+$1.47M
4
DUK icon
Duke Energy
DUK
+$1.36M
5
JEF icon
Jefferies Financial Group
JEF
+$1.12M

Sector Composition

Rank Sector Weight
1 Technology 19.11%
2 Healthcare 16.75%
3 Financials 16.1%
4 Consumer Discretionary 8.77%
5 Communication Services 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IDCC icon
226
InterDigital
IDCC
$8.97B
– –
-5,193
Closed -$316K
IT icon
227
Gartner
IT
$12.2B
– –
-1,848
Closed -$447K
JEF icon
228
Jefferies Financial Group
JEF
$12.8B
– –
-42,432
Closed -$1.12M
KHC icon
229
Kraft Heinz
KHC
$29.4B
– –
-8,131
Closed -$310K
KR icon
230
Kroger
KR
$34.5B
– –
-5,797
Closed -$274K
LIN icon
231
Linde
LIN
$226B
– –
-757
Closed -$218K
MAN icon
232
ManpowerGroup
MAN
$2.61B
– –
-7,819
Closed -$597K
MATX icon
233
Matsons
MATX
$6.23B
– –
-1,559
Closed -$114K
MRSH
234
Marsh
MRSH
$90.9B
– –
-1,548
Closed -$240K
MOS icon
235
The Mosaic Company
MOS
$7.43B
– –
-3,017
Closed -$142K
NKE icon
236
Nike
NKE
$62.4B
– –
-2,470
Closed -$252K
OMC icon
237
Omnicom Group
OMC
$23.2B
– –
-15,029
Closed -$956K
ON icon
238
ON Semiconductor
ON
$31.3B
– –
-8,571
Closed -$431K
OVV icon
239
Ovintiv
OVV
$17.6B
– –
-4,274
Closed -$189K
OXY icon
240
Occidental Petroleum
OXY
$58.5B
– –
-3,959
Closed -$233K
PAG icon
241
Penske Automotive Group
PAG
$14.2B
– –
-3,138
Closed -$329K
REGN icon
242
Regeneron Pharmaceuticals
REGN
$83.2B
– –
-627
Closed -$371K
RRR icon
243
Red Rock Resorts
RRR
$3.58B
– –
-3,682
Closed -$123K
RTX icon
244
RTX Corp
RTX
$302B
– –
-2,205
Closed -$212K
SCCO icon
245
Southern Copper
SCCO
$168B
– –
-20,597
Closed -$951K
SCI icon
246
Service Corp International
SCI
$11.3B
– –
-2,186
Closed -$151K
SPGI icon
247
S&P Global
SPGI
$121B
– –
-626
Closed -$211K
TDC icon
248
Teradata
TDC
$2.57B
– –
-8,950
Closed -$331K
UNFI icon
249
United Natural Foods
UNFI
$2.8B
– –
-6,262
Closed -$247K
VIRT icon
250
Virtu Financial
VIRT
$4.96B
– –
-31,744
Closed -$743K
7 8 9
10
11

Similar funds

MWA
Monograph Wealth Advisors Manhattan Beach, California $1.05B AUM 23.2% 1-Year Est. Return
SFP
Shepherd Financial Partners Winchester, Massachusetts $1.05B AUM 22.07% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return
LAM
L2 Asset Management Wayland, Massachusetts $1.05B AUM 29.07% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
CIA
Compass Ion Advisors Conshohocken, Pennsylvania $1.05B AUM 16.28% 1-Year Est. Return
AA
Apriem Advisors Irvine, California $1.05B AUM 22.09% 1-Year Est. Return

Convergence Investment Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Convergence Investment Partners held 258 positions worth $153M, down 7.3% from $165M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Convergence Investment Partners's Q3 2022 filing shows 56 new, 66 increased, 77 reduced and 59 closed positions. Its largest new stake was Lazard: 34,896 shares worth $1.11M. The largest sale was Pfizer, an estimated $2.41M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

  • Convergence Investment Partners's largest Q3 2022 buy was Lazard: 34,896 shares worth $1.11M.
  • Convergence Investment Partners added most to Gilead Sciences in Q3 2022, an estimated $1.17M increase.
  • Convergence Investment Partners's biggest Q3 2022 reduction was Pfizer, cutting an estimated $2.41M.
  • Convergence Investment Partners fully exited HP in Q3 2022, selling an estimated $1.91M.
  • Convergence Investment Partners's ten largest holdings make up 21% of its $153M portfolio in Q3 2022.
  • Convergence Investment Partners opened 56 new positions and closed 59 in Q3 2022.
  • Convergence Investment Partners's portfolio value fell 7.3% quarter-over-quarter to $153M.

Based on Convergence Investment Partners's 13F filing for Q3 2022, filed 8 Nov 2022.